Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Neoplasma Vol.64, No.2, p.278-282, 2017 |
||
Title: Absence of BRAF mutation in pheochromocytoma and paraganglioma | ||
Author: T. VOSECKA, A. VICHA, T. ZELINKA, P. JENCOVA, K. PACAK, J. DUSKOVA, J. BENES, A. GUHA, L. STANEK, M. KOHOUTOVA, Z. MUSIL | ||
Abstract: Pheochromocytomas and Paragangliomas (PHEO/PARA) are rare endocrine tumors originating from the adrenal medulla. More than 20 genes are involved in the tumorigenesis of these tumors, but a substantial part of the causative genetic events remains unexplained. A recent study has reported the presence of the activating BRAF V600E mutation in PCC, suggesting a role for BRAF activation in tumor development. Other studies have not find this mutation. This study investigates the occurrence of the BRAF V600E mutation in these tumors. A cohort of 64 PHEO/PARA were screened for the BRAF V600E mutation using direct Sanger sequencing and QRT-PCR. All cases investigated displayed wild-type without V600E BRAF mutation Taken together with all previously screened tumors up to date, only 1 V600E BRAF mutation has been found among 427 PCCs. These findings imply that the V600E BRAF mutation is a rare event in PHEO/PARA. |
||
Keywords: pheochromocytoma, paraganglioma, BRAF, mutation | ||
Published online: 14-Mar-2017 | ||
Year: 2017, Volume: 64, Issue: 2 | Page From: 278, Page To: 282 | |
doi:10.4149/neo_2017_215 |
||
|
download file |
|